Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cannabinoids | 3 | 2021 | 90 | 2.070 |
Why?
|
| Receptor, Cannabinoid, CB1 | 3 | 2021 | 68 | 1.540 |
Why?
|
| Potassium Channel Blockers | 2 | 2020 | 32 | 1.260 |
Why?
|
| Potassium Channels | 2 | 2020 | 55 | 1.230 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2020 | 137 | 1.130 |
Why?
|
| High-Throughput Screening Assays | 2 | 2020 | 48 | 1.100 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 3 | 2020 | 8 | 1.010 |
Why?
|
| Ion Channel Gating | 3 | 2017 | 42 | 1.000 |
Why?
|
| Biological Assay | 2 | 2018 | 88 | 0.990 |
Why?
|
| Myocytes, Cardiac | 6 | 2014 | 442 | 0.900 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 2020 | 16 | 0.810 |
Why?
|
| Biosensing Techniques | 2 | 2013 | 51 | 0.800 |
Why?
|
| Calcium Channels, L-Type | 3 | 2007 | 34 | 0.780 |
Why?
|
| GTP-Binding Proteins | 2 | 2018 | 231 | 0.730 |
Why?
|
| Fluorescent Dyes | 4 | 2018 | 191 | 0.700 |
Why?
|
| Hydroxylamines | 1 | 2017 | 20 | 0.630 |
Why?
|
| Sulfonamides | 1 | 2017 | 141 | 0.580 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2014 | 97 | 0.560 |
Why?
|
| Drug Discovery | 2 | 2014 | 94 | 0.560 |
Why?
|
| Membrane Potentials | 5 | 2018 | 200 | 0.520 |
Why?
|
| Patch-Clamp Techniques | 5 | 2014 | 204 | 0.490 |
Why?
|
| Animals, Newborn | 4 | 2009 | 396 | 0.490 |
Why?
|
| Transistors, Electronic | 1 | 2013 | 2 | 0.480 |
Why?
|
| Calcium | 4 | 2007 | 929 | 0.470 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 170 | 0.470 |
Why?
|
| Signal Transduction | 3 | 2020 | 2688 | 0.470 |
Why?
|
| Ion Channels | 1 | 2013 | 72 | 0.470 |
Why?
|
| Myocardium | 3 | 2014 | 1204 | 0.440 |
Why?
|
| Fibroblasts | 2 | 2007 | 902 | 0.430 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2012 | 112 | 0.420 |
Why?
|
| Neurons | 1 | 2017 | 881 | 0.410 |
Why?
|
| Heart Ventricles | 4 | 2009 | 738 | 0.390 |
Why?
|
| Propafenone | 1 | 2010 | 1 | 0.390 |
Why?
|
| Amiloride | 1 | 2010 | 22 | 0.390 |
Why?
|
| Adenoviridae | 2 | 2009 | 295 | 0.360 |
Why?
|
| Naphthalenes | 2 | 2021 | 47 | 0.360 |
Why?
|
| Animals | 12 | 2020 | 20877 | 0.360 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2009 | 11 | 0.350 |
Why?
|
| Cyclic AMP | 1 | 2009 | 223 | 0.330 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2007 | 9 | 0.320 |
Why?
|
| Nisoldipine | 1 | 2007 | 9 | 0.300 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2007 | 93 | 0.300 |
Why?
|
| Cell Line | 3 | 2017 | 1752 | 0.270 |
Why?
|
| Cardiac Volume | 1 | 2005 | 21 | 0.270 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2005 | 27 | 0.270 |
Why?
|
| Chloride Channels | 1 | 2005 | 22 | 0.270 |
Why?
|
| Water-Electrolyte Balance | 1 | 2005 | 43 | 0.270 |
Why?
|
| src-Family Kinases | 1 | 2005 | 91 | 0.260 |
Why?
|
| Integrin beta1 | 1 | 2004 | 48 | 0.250 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2004 | 153 | 0.240 |
Why?
|
| Cytoplasm | 1 | 2004 | 155 | 0.240 |
Why?
|
| Rats | 6 | 2009 | 5300 | 0.240 |
Why?
|
| Cells, Cultured | 5 | 2009 | 2673 | 0.240 |
Why?
|
| Intracellular Membranes | 1 | 2003 | 86 | 0.230 |
Why?
|
| Calmodulin | 1 | 2003 | 53 | 0.230 |
Why?
|
| Heart | 1 | 2007 | 850 | 0.220 |
Why?
|
| Indoles | 1 | 2021 | 146 | 0.190 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 1849 | 0.190 |
Why?
|
| Mice | 4 | 2018 | 8472 | 0.180 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 420 | 0.180 |
Why?
|
| Molecular Structure | 1 | 2020 | 397 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 1745 | 0.170 |
Why?
|
| Benzoxazines | 1 | 2018 | 20 | 0.160 |
Why?
|
| Models, Molecular | 1 | 2020 | 546 | 0.160 |
Why?
|
| Morpholines | 1 | 2018 | 79 | 0.160 |
Why?
|
| Fluorescence | 1 | 2018 | 104 | 0.160 |
Why?
|
| Humans | 6 | 2020 | 68525 | 0.130 |
Why?
|
| Electric Conductivity | 2 | 2004 | 87 | 0.120 |
Why?
|
| Barium | 2 | 2004 | 52 | 0.120 |
Why?
|
| Potassium | 1 | 2013 | 168 | 0.120 |
Why?
|
| Equipment Design | 1 | 2013 | 500 | 0.110 |
Why?
|
| Barbiturates | 1 | 2010 | 3 | 0.100 |
Why?
|
| Carbachol | 1 | 2010 | 34 | 0.100 |
Why?
|
| Isoxazoles | 1 | 2010 | 22 | 0.100 |
Why?
|
| Acetylcholine | 1 | 2010 | 64 | 0.090 |
Why?
|
| Biological Transport | 1 | 2010 | 210 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2010 | 53 | 0.090 |
Why?
|
| Heart Atria | 1 | 2010 | 206 | 0.090 |
Why?
|
| Xanthenes | 1 | 2009 | 18 | 0.090 |
Why?
|
| Aniline Compounds | 1 | 2009 | 52 | 0.090 |
Why?
|
| beta-Galactosidase | 1 | 2009 | 88 | 0.090 |
Why?
|
| Young Adult | 1 | 2020 | 5708 | 0.090 |
Why?
|
| Flecainide | 1 | 2007 | 3 | 0.080 |
Why?
|
| 4-Aminopyridine | 1 | 2007 | 5 | 0.080 |
Why?
|
| Electrophysiology | 1 | 2007 | 160 | 0.080 |
Why?
|
| Atrial Fibrillation | 1 | 2010 | 248 | 0.080 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2007 | 138 | 0.080 |
Why?
|
| Adolescent | 1 | 2020 | 8903 | 0.080 |
Why?
|
| Diltiazem | 1 | 2007 | 25 | 0.080 |
Why?
|
| Calcium Signaling | 1 | 2007 | 97 | 0.070 |
Why?
|
| Angiotensin II | 1 | 2007 | 220 | 0.070 |
Why?
|
| Protein Kinase C | 1 | 2007 | 270 | 0.070 |
Why?
|
| Osmotic Pressure | 1 | 2005 | 8 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2007 | 954 | 0.070 |
Why?
|
| Myocardial Contraction | 1 | 2007 | 383 | 0.070 |
Why?
|
| Ventricular Function | 1 | 2005 | 93 | 0.070 |
Why?
|
| Isoproterenol | 1 | 2004 | 163 | 0.060 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2004 | 92 | 0.060 |
Why?
|
| Colforsin | 1 | 2003 | 42 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 322 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 376 | 0.060 |
Why?
|
| Transfection | 1 | 2004 | 782 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 659 | 0.050 |
Why?
|
| Male | 1 | 2020 | 37281 | 0.040 |
Why?
|